Outbreak Investigation of Marek’s Disease in Chickens in Central and Western Ethiopia Yobsan Tamiru, Habtamu Mekonnen, Bayeta Senbata, Demessa Negessu, Abde Aliyi, Begna Bulcha, Abriham Kebede, Waktola Tadesse, Debela Abdeta, Lipi Buch Abstract BackgroundMarek’s Disease (MD) is an economically devastating poultry disease that causes substantial livestock losses and drives up overall health management costs. There was no study conducted on isolation and molecular detection of Marek’s disease virus (MDV) in extensively managed local breed chickens in some parts of Central and Western Ethiopia.MethodsThe present study was conducted from September 2021 to October 2022 with the aim of isolation and molecular detection of MDV suspected from outbreak cases in chickens in Central and Western Ethiopia. A total of 94 pooled samples were collected from clinically suspected chickens from four areas, namely, Mako, Guto Gida, Holeta, and Sebeta subcity. Samples were collected from chickens in both intensive and extensive production systems, but nonvaccinated birds against MDV were obtained only from the extensive system.ResultFrom the clinical samples tested based on quantitative real‐time PCR, 75 (79.78%; 75/94) tested positive for meq gene of the virus. Of these, 36.17% (34/94) of the positive samples were obtained from the feather (34/41) and the rest (43.62%; 41/94) were obtained from postmortem tissue (41/53) samples. From the overall prevalence of 79.78% (75/94), the highest score was recorded in Holeta town (95.65%), followed by Mako District (88.89%), Sebeta Subcity (62.5%), and Guto Gida District (57.89%). Though there are confounding factors such as vaccination status, significantly (p = 0.04) higher real‐time PCR positive results were obtained in exotic breeds. From 10 pooled liver samples, all samples (100%) tested positive for the virus using real‐time PCR. Similarly, all examined organs showed complete positivity: kidney (10/10, 100%) and spleen (10/10, 100%). However, from six pooled samples of proventriculus samples, only one (1/6, 16.67%) sample was positive for the virus, whereas 34 (82.9%) pooled feather follicles from clinically sick chickens were positive for MDV1. From a total of 75 real‐time PCR positive samples inoculated into DF‐1 cells for virus isolation, 45 (60%) of them were able to show cytopathic effects (CPEs) on the cell line up to the third passage. The seven (40%) feather samples remained negative against the test until the third passage.ConclusionThis study provides critical insights into the isolation and molecular detection of MDV in chickens from Central and Western Ethiopia, highlighting its significant impact on poultry health and productivity. Detailed genetic characterization of the virus and differentiation of the vaccinal strain from the natural infection in exotic breeds are necessary to have effective prevention and control. Experimental studies are also needed to evaluate differences in susceptibility to MDV among local and exotic poultry breeds. 1. Introduction Poultry production has a tremendous role in the economy of developing countries like Ethiopia. It has become a significant component of agricultural sector in Ethiopia, contributing to food production and house food security [, ]. To promote this, the Ministry of Agriculture in the country has developed a national plan called bounty of basket and more specifically put its focus toward development of small and commercial scales of poultry enterprises with the aim of increasing meat and egg productions and then ensuring food security (Ethiopia National Poultry Development Strategy, 2022–2031). Despite these all plans, the prevalence of various poultry diseases poses significant challenges to the sector []. Among viral diseases affecting chickens, Marek’s disease (MD) is one of most economically important, causing substantial morbidity and mortality rates in both backyard and commercial poultry farms [, ]. MD is a highly oncogenic, lymphoproliferative, and neuropathic viral disease of gallinaceous birds that severely impacts the chicken production sector due to reduced egg production and carcass rejection [–]. This disease significantly affects poultry, thereby impacting the private sector and national economy by reducing production and productivity and causing high fatality rate. In susceptible flocks, it can lead to large levels of mortality in vulnerable birds and substantial economic losses due to an overall cost of health management [, ]. MD is a major obstacle to the development of the poultry industry and a significant deterrent to investment in this sector [, ]. The disease has been introduced into Ethiopia through exotic breeds and is now a growing concern for poultry farming systems. It is commonly found in Ethiopia and contributes to substantial health and mortality challenges in chickens across diverse production systems []. A study on MD outbreaks in a commercial poultry farm in Central Ethiopia reported a 46% mortality rate, with similar rates found in local chicken breeds, indicating the fatality of MD even in indigenous breeds []. Conducting genetic analyses of virus isolates and developing effective vaccines using local strains are essential []. Although it poses a serious challenge to the poultry sector, limited research has been conducted on the current status of MD, particularly its molecular characteristics in Ethiopia [, ]. Majority of the studies so far conducted in Ethiopia were on intensively managed chickens. No research has specifically addressed the current molecular status of MD in extensively managed and unvaccinated local breed chickens particularly in some parts of Central and Western Oromia, Ethiopia, despite its significant impact in the area. Some of the research studies conducted on local breeds mainly focus on serological status of the disease [, ]. Therefore, the objectives of this study include investigation of the outbreak and isolation and molecular detection of Marek’s disease virus (MDV) in both intensively managed exotic breed chickens and extensively managed local breed chickens in Central and Western Ethiopia. 2. Materials and Methods 2.1. Description of the Study Area This study was conducted in MD outbreak areas, particularly in Mako from Buno Bedelle, Holeta from West Shewa, Sebeta Subcity from Sheger City, and Guto Gida District from East Wollega Zone (Figure ) from September 2021 to October 2022. 2.2. Study Animal The study evaluated chickens raised under both intensive and extensive production system that were affected by MD outbreaks. Chickens displaying clinical symptoms indicative of MD such as depression, weight loss, blindness, and partial leg paralysis were included in this study. All age and sex groups were part of the investigation. A total of 94 pooled samples were collected from 38 chickens showing signs of illness. These included 36 samples from Mako District, 23 from Holeta, 16 from Sebeta Subcity, and 19 from Guto Gida. Specifically, 8 pooled tissues of ischiatic nerves (each with three tissues), 41 pooled feather samples (each with four to five feather follicles), and 10 pooled samples each from the liver, kidney, and spleen tissues (each with three tissues), along with 6 pools of proventriculus, were collected. Totally, 41 pooled feathers and 53 pooled tissue samples were collected. The number of examined chickens based on their breeds is depicted in Table . 2.3. Study Design and Sampling Method An outbreak case‐based study was conducted based on reports of active MDV outbreaks to collect samples from clinically affected chickens. The extensively managed local breed chickens had no history of MDV vaccination, as confirmed by local veterinary professionals, whereas those chickens under intensive management system were vaccinated against MDV. Samples were randomly collected from affected chickens for virus isolation and molecular detection at the Animal Health Institute in Sebeta, Ethiopia. The outbreak cases were identified based on information collected from regional laboratories in the Oromia Regional State and from professionals working in the study area through phone communication. 2.4. Sample Collection and Transportation Sample collections were performed based on the guideline recommended by OIE []. Information on the disease specifics and vaccination history was gathered during sample collection. Clinically suspected chicken samples were individually collected and pooled into groups of three (for tissues) to four (for feathers) based on type and location after collection. These samples were placed in tubes with viral transport media (VTM, pH 7.4) containing phosphate‐buffered solution (PBS) and antibiotics, labeled, and transported under cold conditions to the Animal Health Institute in Sebeta. 2.5. Clinical Examination and Postmortem Examination Clinical signs (paralysis of the legs (unilateral) and wings, with enlargement of peripheral nerves and gray colored iris) in diseased chickens were closely monitored. Clinically affected chickens were identified and sampled, with feather samples taken from clinically ill chickens. All examinations were performed on birds that had died with the case within 8–12 h at the time of sample collection. Characteristic lesions (enlargement of peripheral nerves and visceral tumors) in various organs and tissues were examined and prepared. 2.6. Laboratory Investigation 2.6.1. Sample Preparation Samples were pooled by type and study area. Tissue and feather follicle samples were minced using sterile tools and ground with sterile sand in a mortar and pestle. A 10% (w/v) suspension was made using PBS mixed with 2% antibiotic‐antimycotic solution. The mixture was then centrifuged at 3000 rpm for 10 min. Then, the clear liquid (supernatant) was carefully filtered and stored at −20°C until it was ready to be used for inoculation. 2.7. DNA Extraction The samples were first thawed at room temperature, and then DNA was extracted using the QIAamp DNA Mini Kit (250), following the instructions provided by the manufacturer. Tissue suspensions (200 μL) were mixed with proteinase K and Buffer AL, incubated at 56°C for 30 min, and then mixed with ethanol. The mixtures were processed through QIAmp spin columns with sequential washes using Buffers AW1 and AW2, and finally, Buffer AE was added to elute the DNA. Feather follicle samples were processed in a biosafety cabinet and treated similarly with a longer incubation at 56°C for 30 min (Appendix ). 2.8. Real‐Time Polymerase Chain Reaction All the samples collected from 38 chickens showing signs of the disease were tested for the presence of the MDV gene using quantitative real‐time PCR. Real‐time PCR tests were done according to manufacturer’s instructions, to detect MDV specific meq gene by using QIAamp DNA Mini Kit (250) (QIAGEN) []. Using an Applied Biosystems 7500 Fast Real‐Time PCR thermal cycler, the master mix for each 25 μL reaction was prepared with the following components: 10 μL of Platinum PCR mix, 0.6 μL of forward MDV‐1 primer (5′‐ GGA‐GCC‐GGA‐GAG‐GCT‐TTA‐TC‐3′), 0.6 μL of reverse primer (MDV‐1 (5′‐GGA‐GCC‐GGA‐GAG‐GCT‐TTA‐TC‐3′), 0.6 μL of reverse primer MDV1OPR (5′‐ATC‐TGG‐CCC‐GAA‐TAC‐AGG‐GAA‐3′), 0.8 μL of probe (5′‐CGTCTTACCGAGGATCCCGAACAGG‐3′), 1 μL of BSA (5 mg/mL), and 2 μL of DNase‐ and RNase‐free water (QIAGEN). MDV known positive isolate (5 μL) and DNAase‐free water (5 μL) were used as positive and negative control, respectively. All the reagents were combined in a single reaction tube to create a master mix, ensuring even distribution (Appendixes and ). The tube was then sealed to prevent evaporation during the process. The PCR was carried out with the following protocol: an initial denaturation at 95°C for 15 min, followed by 45 cycles consisting of denaturation at 95°C for 15 s, annealing at 60°C for 15 s, and extension at 72°C for 25 s [, ]. 2.8.1. Virus Culture and Isolation Douglas Foster 1 (DF‐1, chicken fibroblast cell line derived from East Lansing Line (ELL‐0) embryonic fibroblasts) was used for isolation (Appendix ). It was employed on PCR positive samples. All the homogenized samples were spun in a centrifuge at 3000 rpm for 20 min at 4°C. After that, the clear supernatants were collected and used for virus culture. To assess the presence of the virus, 0.1 mL of the clarified tissue homogenate was transferred onto confluent DF‐1 cell monolayers maintained in 25 cm2 tissue culture flask, following the cell culture standard procedure described by Freshney []. The inoculated cells were placed in an incubator set to 37°C, with 5% CO2 and 100% humidity. They were gently shaken every 15 min over the course of an hour to help the virus attach to the cells. After this incubation period, the virus‐containing solution was carefully removed, and the infected cells were washed with PBS to remove any unabsorbed virus particles. Then, 0.4 mL of GMEM supplemented with 2% calf serum was added. Following inoculation, the DF‐1 cell cultures were maintained at 37°C in a humidified incubator supplied with 5% CO2 for 5 days. The cultures were examined each day using an inverted microscope to monitor the development of cytopathic changes associated with viral replication. Samples that showed no detectable cytopathic effects (CPEs) were subjected to two additional blind passages, resulting in a total of three passages. Cultures remaining free of CPEs after the third passage were considered negative for the presence of infectious virus. 2.9. Ethical Approval and Informed Consent All samples were collected exclusively from chickens that had died naturally from the condition within the past 12 h, ensuring that no live animals were harmed, handled, or monitored for the purpose of this study. Consequently, standard live‐animal handling, weight checks, or health monitoring procedures were not applicable to this protocol. The research design and sampling plan were reviewed and approved by the Animal Welfare and Research Ethics Review Committee (AWRERC) of Wollega University, under the ethical approval number Vetm 21/8/2022‐25/8/2022. The full study protocol submitted to and approved by the ethics committee has been provided as depicted in Appendix 1. Every step of this investigation was carried out in accordance with recognized ethical guidelines at the institutional, national, and international levels. Additionally, explicit informed consent was obtained from the flock owners before performing postmortem examinations on the deceased chickens, in full respect of institutional ethical standards and poultry owner rights. 2.10. Data Management and Analysis All data from the laboratory tests were carefully coded and entered into Microsoft Excel for organization and review. Before analysis, the data were thoroughly checked for accuracy. Statistical analysis was carried out using R software Version 4.0.3 []. Results were summarized with descriptive statistics, including percentages. The real‐time positivity rate and its proportions between the study area, sample type, and breeds were presented using percentage. The association between the outcomes and variables such as breed, study area, and sample type was analyzed using the Fisher exact test. A p value ≤ 0.05 was considered statistically significant at 95% confidence level. 3. Results 3.1. Field Clinical Examination Field investigation conducted during MD outbreak revealed that the affected chickens displayed suggesting signs of the disease, including blindness, paralysis in their legs and wings, and a noticeable inappetence. When examining the dead chickens, we found swollen ischiatic nerves and distinctive white spots or tumor‐like growths on several organs, such as the liver, kidneys, heart, proventriculus, and spleen (Figure ). 3.2. Real‐Time Polymerase Chain Reaction Out of the 94 pooled samples tested using real‐time PCR to detect the Meq gene of MDV, nearly 80% (75 out of 94) tested positive for the MDV1 serotype. Of these, 36.17% (34/94) of the positive samples were obtained from feather follicles and the rest (43.62%; 41/94) were from postmortem tissue samples (Figure ). Out of 15 local breed chickens examined, 8 (53.3%) were positive for the virus, whereas 21 out of 23 exotic breed chickens (91.3%) tested positive. Overall, 29 out of 38 sampled chickens (76.31%) were positive by real‐time PCR. The difference in positivity between the two breed groups was statistically significant (Fisher = 9.01, p = 0.04) (Table ). MDV detection across districts was also determined based on the real‐time PCR assay. Accordingly, the highest proportion of MDV gene detection was observed in Holeta (95.65%), followed by the Mako District (88.89%) and Sebeta Subcity (62.5%). The least proportion was documented in Guto Gida District (57.89%). Significant differences were observed (p < 0.05) between the study areas (Table ). From 10 pooled liver samples, all samples (100%) tested positive for the virus using real‐time PCR. Similarly, both kidney (10/10 ;100%) and spleen (10/10, 100%) showed complete positivity. However, from six pooled samples of proventriculus samples, only one (1/6, 16.67%) sample was positive for the virus, whereas 34 (82.9%) pooled feather follicles from clinically sick chickens were positive for serotype 1 (MDV1) of the virus (Table ). 3.3. Isolation of MDV All samples that tested positive by real‐time PCR were subsequently inoculated onto DF‐1 cell cultures for virus isolation and propagation. CPEs were observed in 45/75 (60%) of the samples. Initially, the CPE appeared as small, rounded cells. Later, it progressed to the formation of small plaques, with foci detaching from the surface of the culture flask. On the third passage, bright and enlarged cells were also observed under an inverted microscope (Figure ). Conversely, no CPEs were observed in the remaining 30 samples (40%). Samples that did not show CPE were blind‐passaged up to third passage to declare negative against the test result. 4. Discussion In the present study, MDV is detected and partially isolated in chickens showing clinical signs in Central and Western Ethiopia. Confirmation of the virus was achieved using molecular diagnostic techniques recommended by the World Organization for Animal Health []. In the present study, both clinical symptoms and postmortem findings indicate MD. This aligns with the previous studies conducted by Fenner et al. [], Gopal et al. [], Swath et al. [], Suresh et al. [], and Priathibha et al. []. The observed leg and wing paralysis is a hallmark symptom of MD, as the virus primarily affects the peripheral nervous system, leading to inflammation and dysfunction in nerves, particularly the sciatic nerve, which controls movement in the legs. Postmortem examination further supported the diagnosis by revealing lymphomas in critical organs such as the liver, kidney, heart, proventriculus, and spleen. This highlights the systemic nature of MD, which can cause solid tumors in multiple organs []. The overall detection rate of the MDV1 gene in this study was similar to earlier findings by Abdel et al. [], Lopez‐Osorio et al. [], and Rahman et al. [], who reported detection rates of 77.6%, 70%, and 70%, respectively. However, it was higher than the rates reported by Abbas and Mehdi [], Bayata et al. [], and Duguma et al. [], which ranged from 7.09% to 62.86%. Conversely, the detection rate in this study was lower than those reported by Davidson and Borenshtain [], Yilmaz et al. [], Mirtneh et al. [], Demeke et al. [], and Aman et al. [], with rates ranging from 80% to 100%. These variations may be attributed to differences in management practices, ecological conditions, sample sizes, and types [], as well as altitude differences reported by Kenenet [] and Birhan []. Breed‐wise analysis in the present study indicated that exotic breeds showed significantly higher real‐time PCR positivity compared to local breeds. This finding is consistent with the report of Mastewal et al. [] in Northwest Ethiopia. However, this observed difference in the current finding should be interpreted with caution because breed comparisons may be influenced by confounding factors such as vaccination status, management practices, and environmental conditions. Therefore, the higher PCR positivity observed in exotic breeds in this study may reflect differences in management, exposure risk, or vaccination history rather than inherent breed susceptibility. Previous studies have suggested that exotic chickens can be more vulnerable to diseases under certain environmental and management conditions due to lower adaptation to local stressors []. In addition, variation in sample size among breed groups might have contributed to the observed differences []. Further studies controlling for potential confounders such as vaccination status, management system, and flock biosecurity are required to clarify the relationship between breed and pathogen occurrence. Significant variation in MDV gene detection was noted across different study areas, with the highest detection rate in the Holeta district. These differences could be due to varying management practices and chicken population densities, as densely populated flocks are at higher risk of disease transmission. MD spreads through airborne fomites and can survive on contaminated surfaces for over a year []. MDV1 gene detection from both feather follicles and postmortem tissues aligns with previous studies by Bulbula et al. [], Lopez‐Osorio et al. [], and Kenenet [], who used qPCR to detect the virus. Among postmortem samples, the liver, kidneys, and spleen showed the highest detection rates, while the proventriculus had the lowest. The differential detection rates among postmortem tissues may reflect the tissue tropism of MDV1. This pattern aligns with the pathophysiology of MD, where lymphoproliferative lesions and viral replication are predominantly observed in visceral organs with high immune activity []. In this study, MDV replication was assessed by observing CPE characteristics in inoculated cells. Out of 75 samples inoculated on DF‐1 cells, 45 showed CPE typical of MDV, such as small, rounded cells, small plaques, with foci detaching from the surface of the culture flask and finally bright and enlarged cells, consistent with OIE []. This finding matches the reports of Heidari et al. [] and Bulbula et al. [] who observed similar CPE in DF‐1 and chicken embryo fibroblast cells. However, only 45 of the 75 qPCR positive samples showed CPE, while 30 did not, even after three passages. This could be attributed to several factors, including variability in the susceptibility of DF‐1 cells to different MDV strains or sample conditions or inhibitory substances or altered sample conditions that interfered with virus replication in vitro. OIE [] also noted that the optimal culture system can affect virus viability. 5. Conclusion and Recommendation This study offers valuable insights into the isolation and molecular detection of MDV in chickens from Central and Western Ethiopia. The findings shed light on the serious effects of the disease on poultry health and productivity in the region. The overall high prevalence of MDV among clinically suspected cases, with notable variation across regions, underscores the need for region‐specific interventions, including improved management practices, targeted vaccination programs, and enhanced surveillance to control the spread of MDV effectively. It also highlights the importance of understanding local risk factors to design tailored strategies for disease prevention and control. Virus isolation using DF‐1 cells showed CPEs in majority of samples, confirming active viral replication in a subset of cases. Detailed genetic characterization of the virus and differentiation of the vaccinal strain from the natural infection in exotic breeds are necessary to have effective prevention and control. Further experimental studies are needed to evaluate differences in susceptibility to MDV among local and exotic poultry breeds. Study Protocol Project title: Outbreak Investigation of Marek’s Disease in Chickens in Central and Western Ethiopia. Institutional affiliation: Wollega University, School of Veterinary Medicine. Ethical approval number: Vetm 21/8/2022‐25/8/2022. Approving body: Animal Welfare and Research Ethics Review Committee (AWRERC), Wollega University.1.Objective and study scope The primary objective of this protocol was to investigate suspected outbreaks of Marek’s disease in poultry flocks across selected districts of Central and Western Ethiopia. The study intended to confirm the virus through clinical, gross pathological, and molecular diagnostic methods.2.Animal welfare and live animal handling exclusion•Live animal involvement: This protocol involved zero (0) interventions, handling, housing, or monitoring of live animals.•Exclusion of welfare checks: Because no live animals were manipulated by the research team, standard animal welfare monitoring procedures (such as routine health checks, temperature taking, or weight monitoring) were not applicable to this study design.•Inclusion criteria: Sampling was strictly restricted to chickens that had been infected naturally by suspected disease within a maximum window of 12 h prior to the team’s arrival. No live animals were euthanized or harmed for the purpose of this research. 3.Owner consent and ethical compliance•Prior to sample collection, the investigative team provided the flock owners with a clear explanation of the study’s purpose.•Formal permission/consent was obtained from each flock owner before conducting postmortem examinations on their deceased poultry.•All procedures adhered strictly to institutional, national, and international guidelines for ethical veterinary research. 4.Field postmortem and tissue sampling procedures•Field necropsies were performed using standard personal protective equipment (PPE) and strict biosecurity measures to prevent the mechanical transmission of pathogens between farms.•Gross pathology: Thorough postmortem examinations were conducted on the deceased chickens to observe and record pathognomonic lesions of Marek’s disease (e.g., enlargement of peripheral nerves and visceral tumors in organs).•Sample collection: Relevant tissue samples (e.g., sciatic nerves, spleen, liver, and feather follicles) were aseptically collected using sterile instruments.•Preservation and transport: Samples for molecular analysis were stored in tube containing viral transport media and transported immediately via cold chain to the virology and molecular laboratory at the Animal Health Institute, Sebeta, Ethiopia, for further processing. 5.Data de‐identification and confidentiality To protect the rights and privacy of the participating poultry farmers, all farm identifiers, owner names, and precise geographic coordinates were de‐identified and coded numerically during data analysis and reporting. Appendix 2: Ethical Clearance